Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.130
+0.240 (8.30%)
At close: Feb 6, 2026, 4:00 PM EST
3.000
-0.130 (-4.15%)
After-hours: Feb 6, 2026, 7:47 PM EST
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $3.2 million as of February 6, 2026. Its market cap has decreased by -56.73% in one year.
Market Cap
3.20M
Enterprise Value
-3.95M
1-Year Change
-56.73%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $3.20M, a decrease of -99.01%. That is a compound annual growth rate of -67.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.20M | 126.84% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 3.26M |
| GRI Bio | 3.16M |
| Lyra Therapeutics | 3.14M |
| Scinai Immunotherapeutics | 2.94M |
| CNS Pharmaceuticals | 2.82M |
| Oragenics | 2.77M |
| Artelo Biosciences | 2.77M |
| Propanc Biopharma | 2.70M |